Follicular Lymphoma

Posted On 2022-05-11 10:50:12

This special series on “Follicular Lymphoma” is edited by Dr. Mark Roschewski, Clinical Director, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA, and Dr. Carla Casulo, Associate Professor of Medicine, Director of the Hematology/Oncology Fellowship Program, University of Rochester, Rochester, NY, USA.

Given our evolving understanding of the pathogenesis and genetic heterogeneity underlying follicular lymphoma, we feel it is important to dedicate a special issue addressing the important topics. Particularly in the current era of a novel targeted agents and novel immunotherapy approaches that are in develop, it is critical that the general oncologist understand the current concepts related to the tumor microenvironment and emerging biomarkers such as measures of minimal residual disease.

Editorial on Follicular Lymphomas
The diversity challenges in follicular lymphoma
Mark Roschewski, Carla Casulo

Review Article on Follicular Lymphomas
Molecular insights into the pathogenesis of follicular lymphoma
Ting Zhou, Stefania Pittaluga, Elaine S. Jaffe

Genetic heterogeneity in follicular lymphoma
Megan Perrett, Jessica Okosun

Tumor microenvironment of follicular lymphoma
Karthik Nath, Hennes Tsang, Maher K. Gandhi

Predicting early progression in follicular lymphoma
Qin Liu, Anjali Silva, Robert Kridel

Frontline management for follicular lymphoma patients: a narrative review
Stefano Luminari, Vittoria Tarantino

Management of relapsed follicular lymphoma
Thomas D. Rodgers, Paul M. Barr

Minimal residual disease in follicular lymphoma
Christiane Pott, Dominique Wellnitz, Marco Ladetto

Novel targeted agents for follicular lymphoma
Connie Lee Batlevi, Franck Morschhauser

Novel immunotherapy in follicular lymphoma: a narrative review
Arushi Khurana, Stephen M. Ansell

Disclosure
The series “Follicular Lymphoma” was commissioned by the editorial office, Annals of Lymphoma without any sponsorship or funding. MR serves as an unpaid editorial board member of Annals of Lymphoma from October 2020 to September 2022. MR and CC served as the unpaid Guest Editors for the series.